ArticleFrontiers in medicine2025
The association between ABO blood type and outcomes following sudden cardiac arrest: a multicenter observational study.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: ABO blood type has been associated with various disease outcomes, but its relationship with outcomes in patients with sudden cardiac arrest (SCA) remains unexplored. Methods: This was a retrospective analysis of adult out-of-hospital cardiac arrest patients with SCA treated at three major branches of the National Taiwan University Hospital between January 2016 and July 2023. The variables examined for their possible influence on the neurological and survival outcomes of patients with SCA were sociodemographic characteristics, pre-existing diseases, resuscitation events, and blood type. The results of a multivariable logistic regression were reported as adjusted odds ratios (aORs) and 95% confidence intervals (CIs). Neurological outcomes were determined by the Cerebral Performance Category (CPC) scale at hospital discharge. Results: No significant differences were found in the prevalence of each blood type between those who survived and those who did not or between those with good (CPC 1-2) or poor (CPC 3-5) neurological outcomes. There was no significant association between survival and blood type; however, patients with blood type AB had a higher probability of good neurological outcomes than those with blood type O (aOR: 1.98, 95% CI: 1.02-3.83, Conclusion: ABO blood type is not associated with survival in patients with SCA, but blood type AB is associated with better neurological outcomes than type O.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.